FerroptoCure Inc.

FerroptoCure is a clinical stage company developing novel new ferroptosis inducing anti-cancer therapy. FerroptoCure has completed a Phase1a trial of the lead project in Japan and seeking partners to out-license and investors.

Address

Tokyo
Japan
Loading